Newsroom | 36518 results

Sorted by: Latest

Medical Devices
-

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the “Issuers”), have closed the upsized offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031 (the “Notes”). In addition, the compa...
-

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq Capital Market. Bone Biologics is now in compl...
-

Verasonics Announces Enhancements to the Vantage® NXT Research Ultrasound Platform Designed to Further Improve Capabilities in Ultrasound Research and Product Development

KIRKLAND, Wash.--(BUSINESS WIRE)--Verasonics, Inc., the leader in research ultrasound, today announced the release of new systems and features for the Vantage NXT Research Ultrasound Platform to advance ultrasound research and product development. New enhancements include Vantage NXT 32LE and 64 System configuration models and Acquisition SDK Option features. This release will be available to all Vantage NXT customers today. Enhancements to Vantage NXT in the Update include: Vantage NXT 32LE an...
-

Qure.ai Recognized Among TIME’s 100 Most Influential Companies of 2025

NEW YORK--(BUSINESS WIRE)--Qure.ai, the world’s most widely adopted digital health innovator, has been named to TIME’s 2025 TIME100 Most Influential Companies list. Now in its fifth year, the TIME100 list highlights companies making an extraordinary global impact through innovation, ambition, and measurable success. TIME’s editorial spotlighted Qure.ai’s work in advancing diagnostic equity through AI, stating: “Trained on one of the world’s largest data sets, Qure.ai’s algorithms are as accurat...
-

Carlsmed Announces Filing of Registration Statement for Proposed Initial Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined....
-

Biocom California’s 2025 Economic Impact Report Highlights Importance of the State’s Life Science Industry -- One of the Top Industries in the Fourth Largest Economy in the World

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today released its 2025 Life Science Economic Impact Report, providing the most comprehensive report to date of the industry’s economic footprint, innovation output and national leadership. According to the report, the life science industry in California generated $396 billion in total business output, supported approximately 1.15 million...
-

Human-Led, AI-Powered: Berry Fertility Launches Smart Compose for Patient Support

SAN FRANCISCO--(BUSINESS WIRE)--Berry Fertility has launched Smart Compose, an AI-powered tool designed to improve patient communication in fertility care....
-

CalmWave Closes Oversubscribed $4.4 Million Follow-On Investment from Third Prime, Bonfire Ventures, Catalyst by Wellstar, and Silver Circle to Transform Hospital Operations

SEATTLE--(BUSINESS WIRE)--CalmWave, creator of the Calm ICU™ and leader in eliminating non-actionable alarms through healthcare data science and Transparent AI, today announced a $4.4 million follow-on round from current investors Third Prime, Bonfire Ventures, Catalyst by Wellstar, and Silver Circle. The capital will be used to further accelerate market penetration driven by strong demand from hospital systems. “We've done what many believed impossible and shown significant reductions in non-a...
-

McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea...
-

Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS) (Sensus or the Company), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces it has entered into a strategic agreement with Radiology Oncology Systems (ROS) to serve as the Company’s primary distribution partner for the U.S. radiation oncology market. Under the terms of the agreement, ROS wi...